Search for: "Teva Pharmaceuticals LLC" Results 41 - 60 of 254
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2021, 4:15 am by Gretchen Miller
Teva Pharmaceuticals “skinny labeling” case has raised eyebrows and piqued interest beyond the usual circles. [read post]
14 Oct 2021, 4:15 am by Gretchen Miller
Teva Pharmaceuticals “skinny labeling” case has raised eyebrows and piqued interest beyond the usual circles. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
8 Oct 2020, 9:59 pm by Patent Docs
What Quantum of Culpable Conduct Is Required for an ANDA Applicant to Induce Infringement? [read post]
24 Apr 2020, 5:24 am by Lawrence B. Ebert
,Sun Pharmaceutical Industries, Inc., and Sun PharmaGlobal FZE’s (collectively, Sun); Teva PharmaceuticalsUSA, Inc. and Actavis Elizabeth LLC’s; and ArgentumPharmaceuticals LLC’s requests for joinder under 35U.S.C. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
In Seedlings Life Science Ventures, LLC v. [read post]
14 Oct 2019, 2:15 pm by Nancy Braman
The finding of nonobviousness means that Actavis, owned by generic drug maker Teva Pharmaceuticals, is enjoined from engaging in the commercial use, offer for sale, or sale of its product covered in its Abbreviated New Drug Application (ANDA) until the expiration of U.S. [read post]